Abstract Human parvovirus B19 (B19) IgG was studied retrospectively in 66 allogeneic bone
marrow transplantation (BMT) patients using an enzyme-linked immunosorbent assay …

We report the results of a survey of parvovirus B19 infection carried out with the aim to
evaluate the frequency and the role of this infection in bone marrow transplant (BMT) …

Due to the preparative regimen necessary, bone marrow transplantation (BMT) consistently
results in severe immunodeficiency, often associated with anaemia, leukopenia and …

To evaluate the occurrence and clinical role of active parvovirus B19 infection in solid organ
and bone marrow transplant recipients, 256 serum samples from 212 transplant patients …

Renal transplant patients were screened for the presence of parvovirus B19, before
transplantation and monthly for 4 months after transplantation, by means of a sensitive …

We report a 61‐yr‐old kidney transplant recipient with human Parvovirus B19 (HPV B19)
infection presenting as a severe pancytopenia 1 month after transplantation. Bone marrow …

Five hundred thirty-three liver transplant recipients were seen for follow-up care over a 6-
month period. Of these, 23 (4.3%) had a hemoglobin level of< or= 9 g/dl, with 19 being …

Parvovirus B19 lytically infects erythroid progenitor cells and thereby causes cessation of
erythropoiesis in infected individuals. Anemia develops only if red cell turnover is increased …

The human parvovirus B19 may produce persistent infections with chronic bone marrow
failure in immunocompromised hosts. Despite poor data on the pathophysiologic basis of …

Objective To study parvovirus B19 infection in immunocompromised subjects such as renal
transplantation recipients. Methods Two cases of B19 infection in renal transplant recipients …